151 related articles for article (PubMed ID: 36106114)
1. DCE-MRI radiomics models predicting the expression of radioresistant-related factors of LRP-1 and survivin in locally advanced rectal cancer.
Li Z; Huang H; Wang C; Zhao Z; Ma W; Wang D; Mao H; Liu F; Yang Y; Pan W; Lu Z
Front Oncol; 2022; 12():881341. PubMed ID: 36106114
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Prediction of Extramural Venous Invasion in Rectal Cancer: Comparison of the Diagnostic Efficacy of Radiomics Models and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Yu X; Song W; Guo D; Liu H; Zhang H; He X; Song J; Zhou J; Liu X
Front Oncol; 2020; 10():459. PubMed ID: 32328461
[No Abstract] [Full Text] [Related]
3. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
4. Multi-parameter diffusion and perfusion magnetic resonance imaging and radiomics nomogram for preoperative evaluation of aquaporin-1 expression in rectal cancer.
Chen Y; Li B; Jiang Z; Li H; Dang Y; Tang C; Xia Y; Zhang H; Song B; Long L
Abdom Radiol (NY); 2022 Apr; 47(4):1276-1290. PubMed ID: 35166938
[TBL] [Abstract][Full Text] [Related]
5. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
6. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
7. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase.
Tang WJ; Kong QC; Cheng ZX; Liang YS; Jin Z; Chen LX; Hu WK; Liang YY; Wei XH; Guo Y; Jiang XQ
Eur Radiol; 2022 Feb; 32(2):864-875. PubMed ID: 34430998
[TBL] [Abstract][Full Text] [Related]
8. The feasibility of MRI-based radiomics model in presurgical evaluation of tumor budding in locally advanced rectal cancer.
Li Z; Chen F; Zhang S; Ma X; Xia Y; Shen F; Lu Y; Shao C
Abdom Radiol (NY); 2022 Jan; 47(1):56-65. PubMed ID: 34673995
[TBL] [Abstract][Full Text] [Related]
9. Association Between DCE-MRI Perfusion Histogram Parameters and EGFR and VEGF Expressions in Different Lauren Classifications of Advanced Gastric Cancer.
Li Z; Zhao Z; Wang C; Wang D; Mao H; Liu F; Yang Y; Tao F; Lu Z
Pathol Oncol Res; 2021; 27():1610001. PubMed ID: 35069035
[No Abstract] [Full Text] [Related]
10. Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms.
Song XL; Ren JL; Zhao D; Wang L; Ren H; Niu J
Eur Radiol; 2021 Jan; 31(1):368-378. PubMed ID: 32767049
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
12. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
[TBL] [Abstract][Full Text] [Related]
13. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
[TBL] [Abstract][Full Text] [Related]
14. Radiomics Features at Multiparametric MRI Predict Disease-Free Survival in Patients With Locally Advanced Rectal Cancer.
Cui Y; Wang G; Ren J; Hou L; Li D; Wen Q; Xi Y; Yang X
Acad Radiol; 2022 Aug; 29(8):e128-e138. PubMed ID: 34961658
[TBL] [Abstract][Full Text] [Related]
15. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
[No Abstract] [Full Text] [Related]
16. MRI-Based Radiomics Features to Predict Treatment Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer: A Single Center, Prospective Study.
Chen BY; Xie H; Li Y; Jiang XH; Xiong L; Tang XF; Lin XF; Li L; Cai PQ
Front Oncol; 2022; 12():801743. PubMed ID: 35646677
[TBL] [Abstract][Full Text] [Related]
17. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer.
Cheng Y; Luo Y; Hu Y; Zhang Z; Wang X; Yu Q; Liu G; Cui E; Yu T; Jiang X
Abdom Radiol (NY); 2021 Nov; 46(11):5072-5085. PubMed ID: 34302510
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of multiparametric MRI-based radiomics model: Potential role for chemotherapeutic benefits in locally advanced rectal cancer.
Cui Y; Yang W; Ren J; Li D; Du X; Zhang J; Yang X
Radiother Oncol; 2021 Jan; 154():161-169. PubMed ID: 32976874
[TBL] [Abstract][Full Text] [Related]
20. Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Zhang Z; Jiang X; Zhang R; Yu T; Liu S; Luo Y
Diagn Interv Radiol; 2021 May; 27(3):308-314. PubMed ID: 34003118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
